l i itatneserpeR stI puorGohuraMsgurDacdeMevdnaohuraM021915195019902002Maruho Hatsujyo Kogyo Co.,Ltd.Maruho Co., Ltd.In 1915, founder Eikuma Koba opened Maruho Shouten as a manufacturer and wholesaler of drugs in Dosho-machi, Osaka. Through its initial business of introducing advanced drugs from overseas and manufacturing and selling them in Japan, the companycontributed to the health and better lives of people. In 1965, the company was renamed Maruho Co., Ltd., our present name. In recent years, Maruho has adopted the strategy of focusing on dermatology and evolved into a company that is trusted by medical professionals and patients. The Companyname Maruho comes from Mulford Company, U.S. (now Merck & Co., Inc.), a U.S. pharmaceutical company, with which Maruho entered into an agreement on dealership in Japan in 1915.Asthma treatment injectionSales of Asthmolysin startsDr. Kade Pharmazeutische Fabrik GMBH (Germany) launched Asthmolysin, an intravenous drug for the treatment of asthma. It became Maruho Shouten’s flagship product and contributed to establishing the Maruho brand.Japan’s first single-use hemorrhoids treatment agent. It is clean, easy to use, and still prescribed for the treatment of patients.It was used by many doctors as Japan’s first drug to reduce swelling and relieve pain in orthopedic diseases.Launched an articular cartilage protective agent as a new product in orthopedics.Started as the springs division within Maruho in 1952, became a company in 1954. Maruho Hatsujyo Kogyo conducts businesses in the three key areas of springs, medical devices and components, and machinery. With its strong consulting ability based on its precise metal processing technology and compact machinery design/manufacturing skills, the Companyresponds to the needs of customers in the automobile and other key industries in Japan, as well as the growing areas of pharmaceutical and medical device industries.1922–1977 Eikuma Koba* In 2007, Maruho won the Porter Prize, a prize which recognizes outstanding business models, for its unique strategy specializing in dermatology.1954–Anticoagulant and blood circulation promoterLaunched Hirudoid (currently Hirudoid Cream)Launched Hirudoid made by Luitpold Welk Pharmaceuticals (Germany).At the time, it was used as an anticoagulant and blood circulation promoter for the treatment of orthopedic and surgical diseases. Mulford Company buildingsSprings businessLeap into the fields of orthopedics and surgery1965–Hemorrhoids treatment agentLaunched Posterisan forte Percutaneous compound anti-inflammatory agent(Ointment)Medical devices and Medical devices and components businesscomponents businessSpecializing in topical drugs1968–20061984–1993Articular cartilage protective agentLaunched Mobilat Launched ArteparonOintmentPorter PrizeMachinery businessMachinery businessEstablishment of topical drug brand and expansion into dermatology1998–2017Transdermal bronchodilatorLaunched Hokunalin TapeLaunched as the world’s first patch-type long-acting bronchodilator.We respect autonomous and specialized business management of each of the Maruho Group companies, which are engaged in various businesses such as medical drugs, diagnostic drugs, medical devices,and self-care. Through co-creation of technologies and know-how with the Group companies, we aim to help realize a society where everyone can live with a smile.History of the Maruho Group
元のページ ../index.html#4